Potomac Capital Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10M Sell
127,386
-27,685
-18% -$2.55M 7.74% 2
2026
Q2
$16M Sell
155,071
-18,731
-11% -$1.1M 10.89% 2
2026
Q1
$6.64M Buy
173,802
+12,402
+8% +$392K 5.77% 2
2025
Q4
$3.52M Buy
+161,400
New +$3.35M 2.83% 7

Other funds holding ATEX

Potomac Capital Management's ATEX Position: Q3 2026 in Review

Potomac Capital Management reduced its Anterix (ATEX) stake by 18% in Q3 2026, selling an estimated $2.55M and leaving 127,386 shares worth $10M. The position accounts for 7.74% of the portfolio, ranked #2.

Potomac Capital Management first reported a position in ATEX in Q4 2025 and has held it in 4 quarters since. The position peaked at $16M in Q2 2026. 177 funds tracked by Wall St. Rank hold ATEX as of Q3 2026.

  • Potomac Capital Management held 127,386 shares of Anterix worth $10M as of Q3 2026.
  • Potomac Capital Management sold 27,685 Anterix shares in Q3 2026, an estimated $2.55M.
  • Anterix made up 7.74% of Potomac Capital Management's portfolio in Q3 2026, its #2 holding.
  • Potomac Capital Management first reported a position in Anterix in Q4 2025 and has held it in 4 quarters since.
  • Potomac Capital Management's Anterix position peaked at $16M in Q2 2026.
  • 177 funds tracked by Wall St. Rank held Anterix as of Q3 2026.

Based on Potomac Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.